The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Quinolones Market During The 2026–2030 Period?
The quinolones market size has experienced steady growth in recent years. It is anticipated to expand from $51.89 billion in 2025 to $54.48 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.0%. This historical market expansion can be credited to factors like the increasing prevalence of bacterial infections, a rise in hospital admissions, strong demand for broad-spectrum antibiotics, the expansion of retail pharmacies, and government initiatives focused on infectious disease control.
The quinolones market is projected to experience substantial expansion over the coming years. Its valuation is set to reach $66.44 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This anticipated growth during the forecast period is primarily driven by advancements in precision medicine, the creation of new quinolone formulations, the widening reach of online pharmacy platforms, increasing public understanding of antimicrobial stewardship, and the growing adoption of digital health monitoring instruments. Key developments expected in this period include enhanced management of antibiotic resistance, the increased availability of generic drugs, the implementation of personalized treatment methods, an uptick in outpatient and home healthcare services, and greater investment in research and development for innovative quinolones.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp
What Major Growth Factors Are Impacting The Quinolones Market?
The escalating threat of antimicrobial resistance is anticipated to stimulate the expansion of the quinolones market in the future. Antimicrobial resistance (AMR) pertains to the capacity of microorganisms, including bacteria, viruses, parasites, and fungi, to withstand the effects of antimicrobial medications. Quinolones exhibit a broad spectrum of activity, rendering them potent against a range of bacteria. Administered for specific infection types, they possess the ability to penetrate various tissues and become a preferred selection when options are scarce. For instance, in October 2025, as per the World Health Organization, a US-based intergovernmental organization, an extensive global examination scrutinized antibiotic resistance prevalence and trends using data from more than 23 million confirmed instances of bloodstream, urinary tract, and gastrointestinal infections and urogenital gonorrhea. These findings originated from reports provided by 104 countries in 2023. Therefore, the growing peril of antimicrobial resistance is propelling the growth of the quinolones market.
How Is The Quinolones Market Examined Through Segment Analysis?
The quinolones market covered in this report is segmented –
1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Which Trends Are Influencing The Direction Of The Quinolones Market?
Leading firms within the quinolones market are prioritizing novel offerings, including fluoroquinolone antibiotic eye drops, to boost their market revenues. These eye drops represent a category of antibiotics specifically designed for addressing bacterial eye infections. An example is the launch of Vigamox by Harrow Health Inc., a US-based pharmaceutical entity, in July 2023. This solution is isotonic, possessing an osmolality of approximately 290 mOsm/kg, and incorporates 5.45 mg of moxifloxacin hydrochloride, equivalent to 5 mg of moxifloxacin base. Packaged in a 3-milliliter bottle, the medication is provided as a sterile ophthalmic solution within a dispensing mechanism comprising a tan polypropylene closure, a dispensing plug, and a natural low-density polyethylene bottle. Vigamox’s use is advised for preventing eye infections both pre- and post-surgery.
Who Are The Prominent Players Across The Quinolones Market?
Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.
Access The Complete Quinolones Market Report:
https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report
Which Region Commands The Largest Share Of The Quinolones Market?
North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Quinolones Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp
Browse Through More Reports Similar to the Global Quinolones Market 2026, By The Business Research Company
Quinolones Market Report 2026
https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report
Quinoa Market Report 2026
https://www.thebusinessresearchcompany.com/report/quinoa-global-market-report
Fluoxetine Market Report 2026
https://www.thebusinessresearchcompany.com/report/fluoxetine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model